Kungsleden AB (publ) is continuing to streamline its property portfolio and is selling 39 properties to NP3 for SEK 760 m. Including these sales, properties worth SEK 2.2 bn have been divested in 2014 in accordance with the company’s strategy. Kungsleden is now taking the next step and is becoming an active buyer again. In the first six months of the year, Kungsleden worked intensively to optimize its property portfolio by measures including selling non-strategic properties and many smaller properties. This has allowed Kungsleden to streamline its property holding and achieve a more efficient portfolio structure. In summary, Kungsleden has sold 58 properties for just over SEK 2.2 bn in a total of 11 different transactions. Average prices exceeded book value by more than 10%. Kungsleden also acquired two properties in Malmö for SEK 66 m. “It’s pleasing that we’ve successfully sold properties for a total profit of some SEK 170 m in the first six months of the year. We’ve managed to capitalize on the favorable market conditions and have completed the streamlining process faster than planned, and at attractive prices. The recent sales in the Norrland region mean that we’re now set to take the next strategic step and become active buyers again,” commented Kungsleden’s CEO Biljana Pehrsson. The sales in Norrland mean that Kungsleden is now exiting ten regions: Borlänge, Falun, Härjedalen, Härnösand, Luleå, Nordmaling, Sollefteå, Sundsvall, Söderhamn and Timrå. All properties in Umeå, except two development projects—Aspgärdan and Laven, were divested. The properties are being acquired by NP3, a well-known and reputable property owner in the Norrland region, who will also take over Kungsleden’s three staff at the regional offices in Umeå on completion. The properties largely comprise industrial and warehousing facilities, with total leasable area of approx. 144 100 sq.m. The sales price after all transaction costs is slightly above book value. Completion is scheduled for 1 September and the profit will be reported in the third quarter of 2014. Kungsleden’s strategy, which was determined with a three-year perspective in 2013, is to focus its property portfolio on selected segments and regions with positive economic growth and sound demand for premises in order to generate attractive returns. Key strategic intermediate goals include realigning the property portfolio to increase the proportion of office space to some 50% and reduce the share of industrial/warehousing to some 35%, and also to increase the share of properties located in Stockholm, Gothenburg and Malmö to at least 50%. These goals were reached in December 2013. Another intermediate goal is to concentrate the property holding from 110 municipalities to 70 in the medium term. The sales completed in the first half of 2014 mean that Kungsleden now owns properties in 95 municipalities. [image]Image: Kedjan 5, Umeå [image]Image: Torsvik 5, Härnösand For more information, please contact: Biljana Pehrsson, Chief Executive of Kungsleden | +46 (0)8 503 052 04 | biljana.pehrsson@kungsleden.se ( biljana.pehrsson@kungsleden.se) Ylva Sarby Westman, Head of Transactions Kungsleden | +46 (0)8 503 052 27 | ylva.sarby.westman@kungsleden.se ( ylva.sarby.westman@kungsleden.se) www.kungsleden.se Detta pressmeddelande finns tillgängligt på svenska på www.kungsleden.se/pressmeddelanden Kungsleden AB (publ) discloses the information in this press release according to the Swedish Securities Markets Act and/or the Swedish Financial Trading Act. The information was provided for public release on 9 July 2014 at 8:00 a.m. Kungsleden’s business concept is to own, manage and improve commercial properties in growth regions in Sweden and to deliver attractive total returns. Kungsleden’s strategies to create value are based on meeting the premises requirements of customers by managing, improving and developing properties and planning consents and by optimising the company’s property portfolio. Kungsleden has been quoted on NASDAQ OMX Stockholm since 1999.
Kungsleden sells 39 properties, exiting 10 regions in
Top 10 Most Recent News Articles
Servier's Data on Tovorafenib Shows Promise in pLGG
New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...
Continue Reading
Novo's Research Unlocks New Insights into Food Noise
Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....
Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup
An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....
Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing
Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era
The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...
Continue Reading
Webull Faces Class Action: Key Details for Investors
What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...
Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched
Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...
Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale
Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...
Continue ReadingTop 5 Most Recently Viewed Articles
Thames Ventures VCT 1 PLC Reports Unaudited NAV for 2024
Thames Ventures VCT 1 PLC Releases Unaudited NAV for 2024 Thames Ventures VCT 1 PLC has provided important updates about its financial status through its unaudited net asset value (NAV). As of June 30, 2024, the NAV stands at 45.9p per share. This announcement is significant for both the company and its investors, as understanding the NAV is essential for evaluating the...
Continue Reading
Gap Inc Achieves Impressive Growth and Market Expansion
Gap Inc Reports Promising Financial Results Shares of Gap Inc (GAP) saw a significant uptick in early trading on Friday following the announcement of their latest quarterly results. This positive financial report highlighted a stronger performance than expected, showcasing the company's effective strategies and management efforts. Analysts' Positive Outlook on Gap In the...
Continue Reading
The Town Lake Company's Bold New Industrial Project Launch
The Town Lake Company Initiates New Industrial Development Benchmark Business Parks, a division of The Town Lake Company, has proudly initiated construction on its latest small-bay industrial project. This significant development is located at 1433 Chris Lane and will encompass an impressive 84,200 square feet of innovative tilt-wall flex industrial space. The project is...
Continue Reading
Investors Unite in Class Action Against Everus Construction Group
Opportunity for Investors in Everus Construction Group, Inc. In recent developments, investors of Everus Construction Group, Inc. (NYSE: ECG) have found themselves in the midst of a class action lawsuit that has drawn considerable attention. This lawsuit targets purchases made by investors during a specified period, raising important questions about the company's...
Continue Reading
Lam Research Board Approves Quarterly Dividend Announcement
Lam Research Corporation Declares New Dividend Lam Research Corporation (Nasdaq: LRCX) has recently made an important announcement regarding its financial strategy. In their latest meeting, the company's Board of Directors approved a quarterly dividend of $0.23 per share for all common stockholders. This decision reflects Lam Research's commitment to providing value to...
Continue Reading